These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins. Dansette PM; Jaoen M; Pons C Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989 [TBL] [Abstract][Full Text] [Related]
10. Not all statins interfere with clopidogrel during antiplatelet therapy. Mach F; Senouf D; Fontana P; Boehlen F; Reber G; Daali Y; de Moerloose P; Sigwart U Eur J Clin Invest; 2005 Aug; 35(8):476-81. PubMed ID: 16101667 [TBL] [Abstract][Full Text] [Related]
11. Magnesium cation effect on passive diffusion of statin molecules: molecular chromatography approach. Sarr FS; Guillaume YC; André C J Pharm Biomed Anal; 2008 Jul; 47(3):651-7. PubMed ID: 18378106 [TBL] [Abstract][Full Text] [Related]
12. DFT study on hydroxy acid-lactone interconversion of statins: the case of atorvastatin. Hoffmann M; Nowosielski M Org Biomol Chem; 2008 Oct; 6(19):3527-31. PubMed ID: 19082153 [TBL] [Abstract][Full Text] [Related]
13. Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations. da Costa RF; Freire VN; Bezerra EM; Cavada BS; Caetano EW; de Lima Filho JL; Albuquerque EL Phys Chem Chem Phys; 2012 Jan; 14(4):1389-98. PubMed ID: 22159045 [TBL] [Abstract][Full Text] [Related]
14. Statins (HMG-coenzyme A reductase inhibitors)-biomimetic membrane binding mechanism investigated by molecular chromatography. Sarr FS; André C; Guillaume YC J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 868(1-2):20-7. PubMed ID: 18479982 [TBL] [Abstract][Full Text] [Related]
15. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964 [TBL] [Abstract][Full Text] [Related]
16. Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors. Park WK; Kennedy RM; Larsen SD; Miller S; Roth BD; Song Y; Steinbaugh BA; Sun K; Tait BD; Kowala MC; Trivedi BK; Auerbach B; Askew V; Dillon L; Hanselman JC; Lin Z; Lu GH; Robertson A; Sekerke C Bioorg Med Chem Lett; 2008 Feb; 18(3):1151-6. PubMed ID: 18155906 [TBL] [Abstract][Full Text] [Related]
17. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking. Karthik MV; Satya Deepak MV; Shukla P Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940 [TBL] [Abstract][Full Text] [Related]
18. DFT study on hydroxy acid-lactone interconversion of statins: The case of fluvastatin. Grabarkiewicz T; Grobelny P; Hoffmann M; Mielcarek J Org Biomol Chem; 2006 Dec; 4(23):4299-306. PubMed ID: 17102875 [TBL] [Abstract][Full Text] [Related]
19. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096 [TBL] [Abstract][Full Text] [Related]
20. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]